Haemonetics Net Profit Margin 2010-2025 | HAE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Haemonetics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Haemonetics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$209.7B
Boston Scientific (BSX)	$154.8B
Stryker (SYK)	$148.4B
EssilorLuxottica (ESLOY)	$131.5B
Medtronic (MDT)	$114.8B
Lonza Group Ag (LZAGY)	$49.7B
Haleon (HLN)	$43.1B
ResMed (RMD)	$37.6B
GE HealthCare Technologies (GEHC)	$34.9B
Agilent Technologies (A)	$33.1B
Terumo (TRUMY)	$24.3B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$19.9B
Zimmer Biomet Holdings (ZBH)	$18.8B
Baxter (BAX)	$14.3B
Smith & Nephew SNATS (SNN)	$13.1B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.8B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.7B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B
AdaptHealth (AHCO)	$1.2B